Levocetirizine Dihydrochloride



Levocetirizine Dihydrochloride





(lev oh seh teer’ ih zeen)

Xyzal

PREGNANCY CATEGORY B


Drug class

Antihistamine


Therapeutic Actions

Potent histamine (H1) receptor antagonist; inhibits histamine release and eosinophil chemotaxis during inflammation, reducing swelling and inflammatory response.


Indications



  • Relief from symptoms of seasonal and perennial allergic rhinitis in adults and children 6 mo and older


  • Treatment of uncomplicated skin effects in chronic idiopathic urticaria in patients 2 yr and older



Available Forms

Tablets—5 mg; oral solution—2.5 mg/5 mL


Dosages

Adults and children 12 yr and older

5 mg/day PO, taken in the evening.

Children 6–11 yr

2.5 mg/day PO taken in the evening.

Children 6 mo–5 yr

1.25 mg (½ tsp oral solution) PO once daily in the evening.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 21, 2016 | Posted by in NURSING | Comments Off on Levocetirizine Dihydrochloride

Full access? Get Clinical Tree

Get Clinical Tree app for offline access